Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Veozah™ (fezolinetant) – New drug approval
May 12, 2023 - The FDA announced the approval of Astellas’ Veozah (fezolinetant), for the treatment of moderate to severe vasomotor symptoms due to menopause.
